Literature DB >> 4015754

Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease.

W J Serfontein, J B Ubbink, L S De Villiers, C H Rapley, P J Becker.   

Abstract

Preliminary evidence is presented that plasma pyridoxal-5-phosphate levels are considerably and significantly reduced (P less than 0.0001) in patients suffering from myocardial infarction when compared to a healthy control group.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4015754     DOI： 10.1016/0021-9150(85)90113-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


  3 in total

1.  Repression of anti-apoptotic genes via AP-1 as a mechanism of apoptosis induction in ventricular cardiomyocytes.

Authors:  A Schlieper; M Anwar; J Heger; H M Piper; G Euler
Journal:  Pflugers Arch       Date:  2006-11-18       Impact factor: 3.657

2.  No sensory neuropathy during pyridoxine treatment in homocystinuria.

Authors:  C Mpofu; S M Alani; C Whitehouse; B Fowler; J E Wraith
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

3.  Compartmentalization of pyridoxal-5'-phosphate during the acute phase of myocardial infarction.

Authors:  W J Vermaak; H C Barnard; E M Van Dalen; G M Potgieter; H Van Jaarsveld; S J Myburgh
Journal:  Klin Wochenschr       Date:  1988-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.